|
|
|
Insider
Information: |
Friedman Paul A |
Relationship: |
Director |
City: |
Palo Lato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
964,465 |
|
Indirect Shares
|
670,540 |
|
|
Direct
Value |
$60,716,225 |
|
|
Indirect Value
|
$161,810,515 |
|
|
Total
Shares |
1,635,005 |
|
|
Total
Value |
$222,526,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
14.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director |
2020-05-26 |
256,813 |
2020-05-26 |
15,000 |
Premium* |
|
Bausch & Lomb, Inc. |
BOL.04 |
Director |
2007-10-26 |
0 |
2004-06-01 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2014-12-24 |
3,000 |
2014-12-24 |
0 |
Premium* |
|
Madrigal Pharmaceuticals Inc |
MDGL |
|
2024-04-08 |
185,735 |
2024-04-08 |
655,540 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-04-03 |
18,819 |
2016-10-03 |
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2017-11-29 |
0 |
Premium* |
|
Prelude Therapeutics Inc |
PRLD |
Director |
2020-09-29 |
500,098 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BOL.04 |
Bausch & Lomb, Inc. |
Director |
|
2007-09-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
776 |
2,286 |
0 |
- |
|
BOL.04 |
Bausch & Lomb, Inc. |
Director |
|
2007-10-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
865 |
0 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2010-07-07 |
4 |
OE |
$5.46 |
$155,034 |
D/D |
25,142 |
289,707 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2011-02-23 |
4 |
OE |
$8.64 |
$172,800 |
D/D |
20,000 |
309,707 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2012-07-10 |
4 |
OE |
$3.11 |
$189,442 |
D/D |
25,186 |
334,893 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2013-05-06 |
4 |
OE |
$9.41 |
$253,088 |
D/D |
23,700 |
391,868 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2013-09-10 |
4 |
OE |
$7.09 |
$2,962,344 |
D/D |
376,789 |
768,657 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-14 |
4 |
OE |
$11.98 |
$122,519 |
D/D |
10,227 |
427,745 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-18 |
4 |
OE |
$3.11 |
$5,653,274 |
D/D |
720,036 |
1,137,554 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-19 |
4 |
OE |
$3.11 |
$127,258 |
D/D |
40,919 |
458,437 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-20 |
4 |
OE |
$3.11 |
$103,731 |
D/D |
33,354 |
450,872 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-11-06 |
4 |
OE |
$9.41 |
$1,861,617 |
D/D |
185,653 |
603,171 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-05-21 |
4 |
OE |
$14.72 |
$333,423 |
D/D |
22,651 |
320,169 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-05-22 |
4 |
OE |
$14.72 |
$1,171,594 |
D/D |
79,592 |
377,110 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-05-26 |
4 |
OE |
$14.72 |
$1,878,552 |
D/D |
127,619 |
425,137 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-05-27 |
4 |
OE |
$14.72 |
$1,017,623 |
D/D |
69,132 |
366,650 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-11-17 |
4 |
OE |
$17.79 |
$1,779,000 |
D/D |
100,000 |
397,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-11-18 |
4 |
OE |
$17.79 |
$2,223,750 |
D/D |
125,000 |
422,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-02-23 |
4 |
OE |
$18.32 |
$916,000 |
D/D |
50,000 |
347,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-03-16 |
4 |
OE |
$18.32 |
$152,184 |
D/D |
8,307 |
305,825 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-03-17 |
4 |
OE |
$18.32 |
$763,816 |
D/D |
41,693 |
339,211 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-08-02 |
4 |
OE |
$18.32 |
$404,249 |
D/D |
22,066 |
277,597 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-08-06 |
4 |
OE |
$18.32 |
$1,427,751 |
D/D |
77,934 |
333,465 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2024-04-03 |
4 |
OE |
$9.45 |
$258,996 |
D/D |
27,407 |
213,142 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2024-04-04 |
4 |
OE |
$9.45 |
$176,810 |
D/D |
18,710 |
204,445 |
0 |
- |
|
97 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|